Source: Davit Kirakosyan
UBS Initiates Coverage on JetBlue Airways
UBS, one of the world’s largest and most respected financial services firms, has initiated coverage on JetBlue Airways Corporation (NASDAQ:JBLU). The firm has come out with a Sell rating for the airline’s stock and a $3 price target. This is despite the potential for JetBlue’s second-quarter (Q2) performance to outstrip expectations. UBS has given an explicit warning that JetBlue faces substantial challenges in maintaining its momentum in the second half of 2025 and beyond, painting a sobering picture for the airline’s future.
Potential Q2 Outperformance for JetBlue
UBS analysts have recognized that JetBlue’s conservative Q2 guidance could pave the way for a slight beat in its performance. They have modeled revenue declines at -6.0% year-over-year, which is better than the market consensus of -6.4%.
In recent times, JetBlue has made significant share gains at LaGuardia, which have been stimulated by competitive dynamics at Newark. Additionally, robust travel trends during the Memorial Day holiday period have likely supported the airline’s results in June. UBS has forecasted Q2 earnings per share (EPS) of -$0.31 for JetBlue. This is marginally better than the -$0.34 estimate put forward by the Street.
Persistent Headwinds Remain for JetBlue
Despite the potential for a slight Q2 outperformance, UBS has highlighted several persistent headwinds that JetBlue is likely to face. These include weak revenue per available seat mile (RASM), higher costs (CASM-ex is estimated to rise by 6.5%), and an absence of near-term catalysts that could drive a sustained earnings recovery.
UBS projects that JetBlue will continue to report quarterly losses throughout the current year. The firm believes that only modest EBIT-level profitability could be possible next year. However, this is contingent on the airline’s revenue metrics accelerating significantly.
Negative Risk-Reward Profile for JetBlue
Given these hurdles, UBS has assessed that the risk-reward profile for JetBlue skews negatively. For the airline to meet profit targets, a steep increase in revenue performance would be required. This is a scenario that UBS deems unlikely under the current market conditions.
The airline industry has been hit hard by the COVID-19 pandemic and the associated travel restrictions. While some airlines have managed to weather the storm better than others, JetBlue appears to be among those struggling to chart a path to recovery.
The UBS report suggests that while there may be short-term positive trends, the long-term outlook for JetBlue remains challenging. The airline’s ability to turn around its fortunes will largely depend on its capacity to navigate the current headwinds and adapt to changing market conditions.
In conclusion, potential investors should exercise caution and consider the risks carefully before making a decision. While the potential for Q2 outperformance could provide a temporary boost to JetBlue’s stock, the long-term challenges highlighted by UBS suggest that the airline’s road to recovery could be a long and difficult one.